Increase of Cheplapharm’s €1.29 Billion Credit Lines

White & Case LLP has advised a bank syndicate on a €1.29 billion increase and amendment of the credit lines for Cheplapharm Arzneimittel GmbH (Cheplapharm). The…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Author: Paolo Bossi

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here